Cas no 84434-23-1 ((E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde)
(E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde Chemical and Physical Properties
Names and Identifiers
-
- (E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde
- (E)-3-(4-tert-butylphenyl)prop-2-enal
- 3-(4-tert-butyl-phenyl)-propenal
- 3-[4-(1,1-dimethylethyl)phenyl]-2-propenal
- 4-tert.-Butyl-zimtaldehyd
- 4-tert-butylcinnamaldehyde
- EINECS 282-823-7
- p-tert-Butylcinnamaldehyde
- p-tert-butylcinnamic aldehyde
- 84434-23-1
- 3-(4-(tert-Butyl)phenyl)acrylaldehyde
- SCHEMBL2294016
- (E)-3-(4-tert-butylphenyl)acrylaldehyde
- AKOS006274227
- EN300-1866003
- AC-17567
- 3-(4-tert-Butyl-phenyl)propenal
- 3-(4-tert-butylphenyl)prop-2-enal
- 3-(4-t-butylphenyl)propenal
- CS-0349884
- 86604-07-1
- EC 282-823-7
- ICSATJUWLAEQQU-SNAWJCMRSA-N
-
- Inchi: 1S/C13H16O/c1-13(2,3)12-8-6-11(7-9-12)5-4-10-14/h4-10H,1-3H3/b5-4+
- InChI Key: ICSATJUWLAEQQU-SNAWJCMRSA-N
- SMILES: O=C/C=C/C1C=CC(=CC=1)C(C)(C)C
Computed Properties
- Exact Mass: 188.12000
- Monoisotopic Mass: 188.120115130g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 14
- Rotatable Bond Count: 3
- Complexity: 202
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.5
- Topological Polar Surface Area: 17.1?2
Experimental Properties
- PSA: 17.07000
- LogP: 3.19620
(E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde Customs Data
- HS CODE:2912299000
- Customs Data:
China Customs Code:
2912299000Overview:
2912299000. Other cyclic aldehydes without other oxygen-containing groups. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:5.5%. general tariff:30.0%
Declaration elements:
Product Name, component content, use to, Appearance of tetraformaldehyde
Summary:
2912299000. other cyclic aldehydes without other oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0%
(E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A019108934-1g |
(E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde |
84434-23-1 | 95% | 1g |
$459.98 | 2023-08-31 | |
| Crysdot LLC | CD12026141-1g |
(E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde |
84434-23-1 | 95+% | 1g |
$518 | 2024-07-24 |
(E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde Related Literature
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
-
Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
-
Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
-
Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
Additional information on (E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde
(E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde (CAS No. 84434-23-1): A Versatile Intermediate in Modern Chemical Biology and Medicinal Chemistry
(E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde, identified by its CAS number 84434-23-1, is a significant organic compound that has garnered considerable attention in the fields of chemical biology and medicinal chemistry. This α,β-unsaturated aldehyde features a conjugated system with a phenyl ring substituted at the para position with a tert-butyl group, making it a valuable scaffold for the synthesis of various pharmacologically active molecules. The compound’s unique structural attributes not only facilitate its utility as a building block in organic synthesis but also contribute to its potential applications in drug discovery and material science.
The (E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde molecule is characterized by its aldehyde functionality, which serves as a reactive site for further chemical transformations. The presence of the tert-butyl group enhances the steric bulk of the phenyl ring, influencing the compound’s electronic properties and reactivity. This steric effect can be exploited to modulate the binding affinity and selectivity of derived compounds, making it particularly useful in the design of novel therapeutic agents.
In recent years, there has been growing interest in exploring the pharmacological potential of α,β-unsaturated aldehydes due to their ability to interact with biological targets through multiple mechanisms. Research has demonstrated that such compounds can act as electrophiles, participating in Michael additions, aldol reactions, and other nucleophilic additions, which are pivotal in constructing complex molecular architectures. The (E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde molecule, with its electron-withdrawing aldehyde group and electron-donating tert-butyl group, offers an ideal balance for such transformations.
One of the most compelling applications of (E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde is in the synthesis of small-molecule inhibitors targeting enzyme-catalyzed processes. For instance, studies have shown that derivatives of this compound can inhibit enzymes involved in inflammatory pathways by competing with natural substrates or covalently modifying active sites. The tert-butyl substituent not only provides steric hindrance to improve selectivity but also enhances metabolic stability, making it an attractive feature for drug candidates.
Moreover, the conjugated system of (E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde lends itself to applications in material science, particularly in the development of organic semiconductors and optoelectronic materials. The compound’s ability to form π-stacking interactions with other aromatic molecules makes it a candidate for use in organic light-emitting diodes (OLEDs), photovoltaic cells, and sensors. Recent advancements in this field have highlighted the potential of such compounds in creating novel materials with enhanced performance characteristics.
The synthesis of (E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde typically involves palladium-catalyzed cross-coupling reactions or other transition-metal-catalyzed processes that allow for efficient construction of the desired carbon-carbon bonds. These synthetic strategies have been refined over recent decades, enabling access to complex derivatives with high yields and purity. The compound’s stability under various reaction conditions further underscores its utility as an intermediate in multi-step synthetic routes.
Recent research has also explored the biological activity of (E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde derivatives, particularly those targeting neurological disorders. Studies have indicated that certain analogs exhibit neuroprotective properties by modulating oxidative stress and inhibiting key enzymes involved in neurodegeneration. The aldehyde group’s ability to engage with biological targets through covalent or non-covalent interactions has been leveraged to develop compounds with enhanced bioavailability and target specificity.
The pharmaceutical industry has recognized the importance of such versatile intermediates like (E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde in accelerating drug discovery pipelines. By providing a scaffold that can be readily modified through various chemical transformations, this compound enables medicinal chemists to explore diverse structural motifs without starting from scratch. This approach not only saves time but also reduces costs associated with synthetic chemistry.
In conclusion, (E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde (CAS No. 84434-23-1) represents a cornerstone in modern chemical biology and medicinal chemistry. Its unique structural features make it an indispensable tool for synthesizing pharmacologically relevant molecules with applications ranging from drug development to advanced materials. As research continues to uncover new methodologies for functionalizing this scaffold, its importance is expected to grow further, driving innovation across multiple scientific disciplines.
84434-23-1 ((E)-3-(4-(tert-Butyl)phenyl)acrylaldehyde) Related Products
- 13586-68-0(3-(4-(tert-Butyl)-2-methylphenyl)acrylaldehyde)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)